BURLINGTON, North Carolina -- LabCorp has received emergency use authorization from the Food and Drug Administration for its Pixel at home coronavirus test kit. The COVID-19 At Home Test Kit allows ...

Labcorp launched a first-of-its-kind, at-home diabetes risk testing kit. Labcorp is the only commercial lab to offer Weavr Health’s Velvet blood collection device, according to a May 16 news release.

Laboratory Corporation of America Holdings LH or LabCorp announced the launch of an at-home collection kit for diabetes screening, which measures hemoglobin A1c (HbA1c) from a small blood sample. With ...

BURLINGTON, N.C. (WJZY) — North Carolina-based LabCorp announced Tuesday that it has received an Emergency Use Authorization from the U.S. Food and Drug Administration for at-home COVID-19 test kits.

(RTTNews) - Life sciences company Labcorp (LH) announced Wednesday the receipt of Emergency Use Authorization (EUA) from the U.S. Food and Drug Administration (FDA) for a combined at-home collection ...

BURLINGTON – With COVID-19 cases again on the rise and flu still a threat, Labcorp has received emergency use authorization from the Food and Drug Administration for a new combination at-home test kit ...

The first at-home mpox testing kit provides patients with convenience and privacy to test for mpox, supports physicians in detection and treatment BURLINGTON, N.C., April 10, 2024 /PRNewswire/ -- ...

North Carolina’s LabCorp has gotten the federal go-ahead for an at-home testing kit for COVID-19, the new coronavirus. It’s the first authorized by the Food and Drug Administration. LabCorp of ...

Editor’s note: LimeLight is a regular feature from WRAL TechWire offering another means of publishing noteworthy news. Be sure to check out more LimeLight worthy news at this link. Labcorp is the only ...

BURLINGTON, N.C.--(BUSINESS WIRE)--Labcorp (NYSE: LH), a leading global life sciences company, today announced the receipt of Emergency Use Authorization (EUA) from the U.S. Food and Drug ...

BURLINGTON, N.C.--(BUSINESS WIRE)--Nearly 10 million people in the United States have a history of systemic or anaphylactic reaction to insect stings, with the risk of a severe and potentially ...